Inhaled nitric oxide for congenital diaphragmatic hernia
Treatments studied
Part of Genetic & congenital, Heart & circulation, Lungs & breathing clinical trials.
This trial tests whether inhaled nitric oxide gas helps newborns with a specific type of congenital diaphragmatic hernia (a hole in the diaphragm that lets organs move into the chest) who have low oxygen and high blood pressure in their lungs.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your baby has a Bochdalek type congenital diaphragmatic hernia
- Born at 34 weeks of pregnancy or later, and less than 14 days old
- Has both severely low oxygen levels (hypoxic respiratory failure) and high blood pressure in the lungs (pulmonary hypertension)
- Does not have a serious heart defect that needs surgery or other treatment right after birth
- Has not received any special lung blood vessel medicines, including inhaled nitric oxide, before this trial
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether inhaled nitric oxide gas can help full-term newborns who have severe breathing problems and high blood pressure in their lungs. It aims to improve oxygen levels and reduce the need for more intensive support.
This trial studies whether stopping inhaled nitric oxide (a breathing medicine) can be safely used in newborns with congenital diaphragmatic hernia (CDH). It may help the team decide the best way to use this medicine during early newborn care.
This trial studies whether sildenafil (a medicine that helps relax blood vessels) can improve outcomes in babies born with a congenital diaphragmatic hernia (CDH) after they’ve had surgery. Babies are selected based on an ultrasound/echo of heart function after repair.
This trial tests whether placing a tiny balloon in the fetus’s windpipe can help lungs develop and improve severe pulmonary (lung) blood pressure in babies with severe congenital diaphragmatic hernia (CDH). It may lower the chance of breathing and circulation problems after birth, but it requires a specialized procedure and close follow-up in Houston.
This study looks at whether an inhaled nitric oxide generator and delivery system can help newborns with high lung blood pressure (pulmonary hypertension). It may help improve oxygen levels during breathing support, but it requires specific medical eligibility and informed consent.
This trial tests a new, smart way to slowly reduce (wean) the inhaled nitric oxide gas that helps babies with a serious lung condition called PPHN. If your baby is already responding well to iNO and needs it for at least 24 hours, this study might help make the weaning process safer and more effective.
Hear when a new Congenital Diaphragmatic Hernia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.